Close
Close
Non small cell lung cancer overview
4145 views
2.8
2.8 from 10 votes

Interview with David Ross Camidge, MD, PhD, Assistant Professor, University of Colorado, Denver, Colorado, USA

Non-small cell lung cancer is currently the single biggest killer from cancer of any disease in the world. It's called non-small cell lung cancer to distinguish it from another rarer type of lung cancer called small cell, which behaves very differently and is treated very differently.

Professor Thomas J. Lynch, MD, Director of Yale Cancer Centre, discusses the oral, once daily investigational targeted therapy Afatinib, and the impact it could have for patients with non-small cell lung cancer who have the EGFR mutation.

If you are a journalist and would like more information please visit: http://www.newshome.com/oncology/

If you are a healthcare professional and would like more information please visit: http://www.inoncology.com/

by Abidemi Uruejoma
6 views 2 days ago
by Abidemi Uruejoma
3 views 2 days ago
by Abidemi Uruejoma
17 views 1 week ago
by Abidemi Uruejoma
30 views 1 week ago
by Abidemi Uruejoma
28 views 1 week ago
by Abidemi Uruejoma
57 views 1 month ago
by Abidemi Uruejoma
76 views 1 month ago
by Abidemi Uruejoma
73 views 1 month ago
2.8
2.8 from 10 votes
Free Newsletter
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
29,163 views
by Christine DuBois
23,741 views
by Abidemi Uruejoma
21,569 views